BRIEF published on 04/10/2025 at 07:05, 13 days ago Relief Therapeutics annonce ses résultats financiers et ses progrès stratégiques pour 2024 Biopharmaceutique Maladies Rares THÉRAPEUTIQUE DE SECOURS Résultats Financiers 2024 Progrès Du Pipeline
BRIEF published on 04/10/2025 at 07:05, 13 days ago Relief Therapeutics Announces 2024 Financial Results and Strategic Progress Biopharmaceutical Relief Therapeutics Rare Diseases 2024 Financial Results Pipeline Progress
PRESS RELEASE published on 04/10/2025 at 07:00, 13 days ago Relief Therapeutics Reports 2024 Financial Results and Provides Corporate Update Relief Therapeutics reports 2024 financial results and provides a corporate update, emphasizing operational achievements, pipeline momentum, and strengthened financial position Biopharmaceutical Corporate Update Relief Therapeutics Rare Diseases 2024 Financial Results
BRIEF published on 03/06/2025 at 07:05, 1 month 17 days ago Relief Therapeutics met fin aux discussions de fusion avec Renexxion Valeur Actionnariale Objectifs Stratégiques THÉRAPEUTIQUE DE SECOURS Renexxion Fin De La Fusion
BRIEF published on 03/06/2025 at 07:05, 1 month 17 days ago Relief Therapeutics Ends Merger Discussions with Renexxion Shareholder Value Relief Therapeutics Strategic Objectives Renexxion Merger Termination
PRESS RELEASE published on 03/06/2025 at 07:00, 1 month 17 days ago Relief Therapeutics Announces Conclusion of Merger Discussions with Renexxion Relief Therapeutics terminates merger discussions with Renexxion after failing to meet key conditions. Company remains well-positioned with robust pipeline and cash reserves Relief Therapeutics Cash Reserves Therapeutic Pipeline Renexxion Merger Discussions
BRIEF published on 02/11/2025 at 07:05, 2 months 12 days ago L'Office européen des brevets accorde un brevet thérapeutique de secours pour le RLF-TD011 Produits Biopharmaceutiques THÉRAPEUTIQUE DE SECOURS RLF-TD011 Brevet Européen Epidermolyse Bulleuse
BRIEF published on 02/11/2025 at 07:05, 2 months 12 days ago European Patent Office Grants Relief Therapeutics Patent for RLF-TD011 Biopharmaceuticals Relief Therapeutics RLF-TD011 European Patent Epidermolysis Bullosa
PRESS RELEASE published on 02/11/2025 at 07:00, 2 months 12 days ago Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011 Relief Therapeutics obtains European Patent Office grant for RLF-TD011, securing patent protection for epidermolysis bullosa treatment. Company advances wound care solution Relief Therapeutics European Patent Office Epidermolysis Bullosa Wound Treatment RLD-TD011
BRIEF published on 01/22/2025 at 07:05, 3 months 1 day ago Relief Therapeutics vend les droits de GOLIKE et se concentre sur la R&D THÉRAPEUTIQUE DE SECOURS Vente GOLIKE Partenariat Nutrisens Stratégie Biopharmaceutique Focus R&D
Published on 04/23/2025 at 02:00, 5 hours 29 minutes ago Silver X Reports Significant Operational and Financial Improvement for the Full-Year and Fourth Quarter of 2024
Published on 04/23/2025 at 00:45, 6 hours 44 minutes ago Quebec Precious Metals Announces Shareholder Approval of Arrangement with Fury Gold
Published on 04/23/2025 at 00:45, 6 hours 44 minutes ago Corporation Métaux Précieux du Québec annonce l’approbation des actionnaires de l’arrangement avec Fury Gold
Published on 04/23/2025 at 00:15, 7 hours 14 minutes ago Boron One Announces Update to Early Warrant Exercise Incentive Program
Published on 04/23/2025 at 00:00, 7 hours 29 minutes ago Medicure to Present Financial Results on April 29, 2025 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2024
Published on 04/23/2025 at 07:00, 29 minutes ago From Lab to Unicorn: Xlife Sciences AG Portfolio Company VERAXA Biotech AG to merge with Voyager Acquisition Corp. listed on NASDAQ
Published on 04/23/2025 at 07:00, 29 minutes ago Oerlikon Metco signs long-term rental agreement on the Reichhold campus
Published on 04/23/2025 at 07:00, 29 minutes ago DKSH Consumer Goods Expands its Food Service Segment by Acquiring Zircon-Swis Fine Foods Pte Ltd in Singapore
Published on 04/23/2025 at 06:45, 44 minutes ago mobilezone receives SBTi validation for scientifically based climate targets
Published on 04/23/2025 at 07:00, 29 minutes ago Chiffre d’affaires 1er trimestre 2025 - Communiqué de presse
Published on 04/22/2025 at 18:13, 13 hours 15 minutes ago ELECTRICITE DE STRASBOURG - Droits de vote au jour de l'avis de réunion de l'AGO du 14 mai 2025
Published on 04/22/2025 at 18:12, 13 hours 17 minutes ago ELECTRICITE DE STRASBOURG - Avis de mise à disposition des rapports 2024, des rapports des CAC et des états financiers
